We also assessed the response to M-100 in human B-cell lymphoma cell lines of the BL and DLBCL type characterized by MYC translocation or amplification [30–35], although the individual MYC mutation profile differed greatly in these cells [36, 37], (Table 1). Here, MYC is linked to B-cell non-Hodgkin lymphoma.